Human PPARG Gene Mutation as Risk Factor for Type 2 Diabetes Melitus: In Silico Analysis


  • Naufal Yafi Rais Wiguna
  • Taufik Hidayat B
  • Putrya Hawa
  • Jonny


Type 2 Diabetes Mellitus, PPARG, Bioinformatics, In Silico, SNPs


Introduction: Type 2 diabetes (T2DM) involves genetic and environmental factors. PPARG, encoding peroxisome proliferator-activated receptor gamma, is one of the key gene in T2DM development. Our study investigates PPARG variants' role as risk factor for T2DM by in silico analysis.

Methods: We identified Single Nucleotide Polymorphisms (SNPs) within the PPARG gene via UniProt and analyzed their effects using Ensembl Variant Effect Predictor (VEP). The VEP analysis provided us four important indicators: impact assessment, Sorting Intolerant from Tolerant (SIFT) score, PolyPhen score, and clinical significance. We also investigated PPARG's interactions with other T2DM-related genes using StringDB.

Results:  In our analysis of 35 UniProt-sourced SNPs, 32 underwent successful VEP analysis.The  SIFT indicators identified 23 of SNPs  as deleterious, The PolyPhen identified 18 of SNPs  as probably damaging . Impact assessments revealed that 27 had a moderate impact  on gene function. Clinically, 8 of the SNPs were considered pathogenic and rs1805192 emerged as a notable risk factor for T2DM. Additionally, StringDB analysis confirmed PPARG's role in the T2DM-associated gene network, from the 25 proteins involved in T2DM, 21 of them exhibit correlations with PPARG.

Discussion: PPARG SNPs variant has a significant impact on T2DM as a risk factor. However, SNPs associated with T2DM vary across different populations.

Conclusion:  Analysis of PPARG genetic variations highlights their significant association with T2DM susceptibility in specific populations. Bioinformatics tools are useful for investigating genetic mutations but require additional research, such as functional studies, to improve reliability as their outcomes are primarily predictions.


Download data is not yet available.

Author Biographies

Naufal Yafi Rais Wiguna

Faculty of Military Medicine, Republic of Indonesia Defense University, Bogor, Indonesia

Taufik Hidayat B

Faculty of Military Medicine, Republic of Indonesia Defense University, Bogor, Indonesia

Putrya Hawa

Faculty of Military Medicine, Republic of Indonesia Defense University, Bogor, Indonesia


Faculty of Military Medicine, Republic of Indonesia Defense University, Bogor, Indonesia

Faculty of Medicine, Jakarta “Veterant” National Development University, Jakarta, Indonesia

Department of Internal Medicine, Gatot Soebroto Central Army Hospital, Jakarta, Indonesia


Khan MAB. Epidemiology of Type 2 diabetes - Global burden of disease and forecasted trends. J Epidemiol Glob Health. 2020;10(1):107-111. doi:10.2991/JEGH.K.191028.001

Ong KL. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet. 2023;402(10397):203-234. doi:10.1016/S0140-6736(23)01301-6

Sun H. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183. doi:10.1016/j.diabres.2021.109119

Lin X. Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025. Sci Rep. 2020;10(1). doi:10.1038/s41598-020-71908-9

Handayani OWK, Nugroho E, ... Determinant of diabetes mellitus focusing on differences of Indonesian culture: Case studies in the Java and outer java region in Indonesia. The Open Public …. Published online 2020.

Khoe LC, Wangge G, Soewondo P, Tahapary DL, ... The implementation of community-based diabetes and hypertension management care program in Indonesia. PLoS …. Published online 2020.

Ligita T, Wicking K, Harvey N, ... The profile of diabetes healthcare professionals in Indonesia: a scoping review. International Nursing …. Published online 2018. doi:10.1111/inr.12418

Hidayat B, Ramadani RV, Rudijanto A, Soewondo P, Suastika K, Siu Ng JY. Direct Medical Cost of Type 2 Diabetes Mellitus and Its Associated Complications in Indonesia. Value Health Reg Issues. 2022;28:82-89. doi:10.1016/j.vhri.2021.04.006

Li J. Association of PPARG gene polymorphisms Pro12Ala with type 2 diabetes mellitus: A meta-analysis. Curr Diabetes Rev. 2019;15(4):277-283. doi:10.2174/1573399814666180912130401

Rehman K. Biochemical investigation of rs1801282 variations in PPAR-γ gene and its correlation with risk factors of diabetes mellitus in coronary artery disease. Clin Exp Pharmacol Physiol. 2020;47(9):1517-1529. doi:10.1111/1440-1681.13339

Sarhangi N. PPARG (Pro12Ala) genetic variant and risk of T2DM: a systematic review and meta-analysis. Sci Rep. 2020;10(1). doi:10.1038/s41598-020-69363-7

Stalin A. Computational analysis of single nucleotide polymorphisms (SNPs) in PPAR gamma associated with obesity, diabetes and cancer. J Biomol Struct Dyn. 2022;40(4):1843-1857. doi:10.1080/07391102.2020.1835724

Zhang Z. Pioglitazone Inhibits Diabetes-Induced Atrial Mitochondrial Oxidative Stress and Improves Mitochondrial Biogenesis, Dynamics, and Function Through the PPAR-γ/PGC-1α Signaling Pathway. Front Pharmacol. 2021;12. doi:10.3389/fphar.2021.658362

Hernandez-Quiles M, Broekema MF, Kalkhoven E. PPARgamma in Metabolism, Immunity, and Cancer: Unified and Diverse Mechanisms of Action. Front Endocrinol (Lausanne). 2021;12(February):1-17. doi:10.3389/fendo.2021.624112

Wei L, Xiao Y, Li L, et al. The Susceptibility Genes in Diabetic Nephropathy. Kidney Diseases. 2018;4(4):226-237. doi:10.1159/000492633

Ng PC, Henikoff S. SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res. 2003;31(13):3812-3814. doi:10.1093/nar/gkg509

Sim NL, Kumar P, Hu J, Henikoff S, Schneider G, Ng PC. SIFT web server: predicting effects of amino acid substitutions on proteins. Nucleic Acids Res. 2012;40(Web Server issue):W452-7. doi:10.1093/nar/gks539

Ristow M, Müller-Wieland D, Pfeiffer A, Krone W, Kahn CR. Obesity Associated with a Mutation in a Genetic Regulator of Adipocyte Differentiation. New England Journal of Medicine. 1998;339(14):953-959. doi:10.1056/nejm199810013391403

Vergotine Z, Kengne AP, Erasmus RT, Yako YY, Matsha TE. Rare mutations of peroxisome proliferator-activated receptor gamma: Frequencies and relationship with insulin resistance and diabetes risk in the mixed ancestry population from South Africa. Int J Endocrinol. 2014;2014. doi:10.1155/2014/187985

Adzhubei IA, Schmidt S, Peshkin L, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7(4):248-249. doi:10.1038/nmeth0410-248

Mustafa HA, Albkrye AMS, AbdAlla BM, Khair MAM, Abdelwahid N, Elnasri HA. Computational determination of human PPARG gene: SNPs and prediction of their effect on protein functions of diabetic patients . Clin Transl Med. 2020;9(1):1-10. doi:10.1186/s40169-020-0258-1

Lv X, Zhang L, Sun J, et al. Interaction between peroxisome proliferator-activated receptor gamma polymorphism and obesity on type 2 diabetes in a Chinese Han population. Diabetol Metab Syndr. 2017;9(1):1-6. doi:10.1186/s13098-017-0205-5

Sarkar P, Bhowmick A, Baruah MP, Bhattacharjee S, Subhadra P, Banu S. Determination of individual type 2 diabetes risk profile in the North East Indian population & its association with anthropometric parameters. Indian J Med Res. 2019;150(4):390-398. doi:10.4103/ijmr.IJMR_888_17

Muntean C, Sasaran MO, Crisan A, Banescu C. Effects of PPARG and PPARGC1A gene polymorphisms on obesity markers. Front Public Health. 2022;10:962852. doi:10.3389/fpubh.2022.962852




How to Cite

Yafi Rais Wiguna, N. ., Hidayat B, T. ., Hawa, P. ., & Jonny, J. (2024). Human PPARG Gene Mutation as Risk Factor for Type 2 Diabetes Melitus: In Silico Analysis. ASEAN Journal of Military and Preventive Medicine, 1(1), 1–12. Retrieved from